Coherus Biosciences Financial Overview
Coherus Biosciences's market cap is currently $168.01M. The company's EPS TTM is $-0.31; its P/E ratio is -0.85; Coherus Biosciences is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
